Post-Traumatic Stress Disorder in Old Age
Conditions
Brief summary
In the elderly, we can see a post-traumatic syndrome associated with an event that occurred before old age that had not previously manifested or not fully manifested. This little-known pathology and notable psychiatric co-morbidities (depression, anxiety) can take in elderly subjects different masks that interfere with diagnosis and treatment. The data in the literature suggest that this Post-Traumatic Stress Disorder with Delayed Expression (TSPT-R) may be related to a deficiency of the executive functions of inhibition, and more particularly a deficit of mental memory inhibition and therefore the removal of unwanted memories.
Interventions
The test Think / No-Think
Sponsors
Study design
Eligibility
Inclusion criteria
\- Regarding the constitution of the group patient (TSPT-R): * Subjects 65 years of age or older * Clinical diagnosis of delayed-onset PTSD according to DSM-5 criteria after 65 years * The traumatic event must have taken place at the latest before 65 years * Affiliated person or beneficiary of a social security scheme. * Written consent before any examination required by research) Regarding the constitution of the control group: * Subjects 65 years of age or older * No diagnosis of PTSD (delayed or not) or history of PTSD (delayed or not) * Affiliated person or beneficiary of a social security scheme. * Written consent before any examination required by the research).
Exclusion criteria
* For both groups: * Acute or chronic cognitive impairment known * GRECO MMSE pathological score less than or equal to the pathological threshold weighted according to level of education and age, namely: * 22 if no diploma * 23 if certificate of study * 25 if patent * 26 if bin or more * Remove one point at each threshold if age\> 80 years * Sensory or motor disorder preventing the passing of different tests * Psychotic disorder * Mood disorder in decompensation (for depression, HAD-D score equal to or greater than 11) * Disorder of the use of a moderate or severe substance (except tobacco). * Patients under guardianship or curatorship.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Inhibition score measured by the Think / No-Think Test | 1 month | the average of the inhibition score measured by the Think / No-Think test as defined by Anderson and Green (2001) and then reviewed by Anderson et al. in 2011 |
Countries
France